{
  "actions": [
    {
      "acted_at": "2018-09-05", 
      "action_code": "Intro-H", 
      "references": [], 
      "text": "Introduced in House", 
      "type": "action"
    }, 
    {
      "acted_at": "2018-09-05", 
      "action_code": "H11100", 
      "committees": [
        "HSIF"
      ], 
      "references": [], 
      "status": "REFERRED", 
      "text": "Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.", 
      "type": "referral"
    }, 
    {
      "acted_at": "2018-09-05", 
      "action_code": "H11100", 
      "committees": [
        "HSJU"
      ], 
      "references": [], 
      "text": "Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.", 
      "type": "referral"
    }, 
    {
      "acted_at": "2018-09-08", 
      "action_code": "", 
      "committees": [
        "HSIF"
      ], 
      "references": [], 
      "text": "Referred to the Subcommittee on Health.", 
      "type": "referral"
    }, 
    {
      "acted_at": "2018-10-09", 
      "action_code": "", 
      "committees": [
        "HSJU"
      ], 
      "references": [], 
      "text": "Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations.", 
      "type": "referral"
    }
  ], 
  "amendments": [], 
  "bill_id": "hr6702-115", 
  "bill_type": "hr", 
  "by_request": false, 
  "committee_reports": [], 
  "committees": [
    {
      "activity": [
        "referral"
      ], 
      "committee": "House Judiciary", 
      "committee_id": "HSJU"
    }, 
    {
      "activity": [
        "referral"
      ], 
      "committee": "House Judiciary", 
      "committee_id": "HSJU", 
      "subcommittee": "Subcommittee on Crime, Terrorism, and Homeland Security", 
      "subcommittee_id": "08"
    }, 
    {
      "activity": [
        "referral"
      ], 
      "committee": "House Energy and Commerce", 
      "committee_id": "HSIF"
    }, 
    {
      "activity": [
        "referral"
      ], 
      "committee": "House Energy and Commerce", 
      "committee_id": "HSIF", 
      "subcommittee": "Subcommittee on Health", 
      "subcommittee_id": "14"
    }
  ], 
  "congress": "115", 
  "cosponsors": [
    {
      "bioguide_id": "B001243", 
      "district": "7", 
      "name": "Blackburn, Marsha", 
      "original_cosponsor": true, 
      "sponsored_at": "2018-09-05", 
      "state": "TN", 
      "title": "Rep", 
      "withdrawn_at": null
    }
  ], 
  "enacted_as": null, 
  "history": {
    "active": false, 
    "awaiting_signature": false, 
    "enacted": false, 
    "vetoed": false
  }, 
  "introduced_at": "2018-09-05", 
  "number": "6702", 
  "official_title": "To clarify the congressional intent behind the requirements relating to immediate suspension orders and corrective action plans under the Controlled Substances Act that were added by the Ensuring Patient Access and Effective Drug Enforcement Act of 2016.", 
  "popular_title": null, 
  "related_bills": [
    {
      "bill_id": "s2493-115", 
      "identified_by": "CRS", 
      "reason": "related", 
      "type": "bill"
    }
  ], 
  "short_title": "DEA Enforcement and Authority Act of 2018", 
  "sponsor": {
    "bioguide_id": "B001257", 
    "district": "12", 
    "name": "Bilirakis, Gus M.", 
    "state": "FL", 
    "title": "Rep", 
    "type": "person"
  }, 
  "status": "REFERRED", 
  "status_at": "2018-09-05", 
  "subjects": [
    "Administrative remedies", 
    "Crime and law enforcement", 
    "Department of Justice", 
    "Drug trafficking and controlled substances", 
    "Licensing and registrations"
  ], 
  "subjects_top_term": "Crime and law enforcement", 
  "summary": null, 
  "titles": [
    {
      "as": "introduced", 
      "is_for_portion": false, 
      "title": "To clarify the congressional intent behind the requirements relating to immediate suspension orders and corrective action plans under the Controlled Substances Act that were added by the Ensuring Patient Access and Effective Drug Enforcement Act of 2016.", 
      "type": "official"
    }, 
    {
      "as": "introduced", 
      "is_for_portion": false, 
      "title": "DEA Enforcement and Authority Act of 2018", 
      "type": "short"
    }, 
    {
      "as": "introduced", 
      "is_for_portion": false, 
      "title": "DEA Enforcement and Authority Act of 2018", 
      "type": "short"
    }, 
    {
      "as": null, 
      "is_for_portion": false, 
      "title": "DEA Enforcement and Authority Act of 2018", 
      "type": "display"
    }
  ], 
  "updated_at": "2019-04-18T16:27:04Z", 
  "url": "https://www.govinfo.gov/bulkdata/BILLSTATUS/115/hr/BILLSTATUS-115hr6702.xml"
}